Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine effects on brain activity dynamics and connectivity
NL-OMON49449Active, not recruiting
- Sponsor
- Leiden University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of atomoxetine (2 arms), sponsored by Leiden University. Primary endpoints: Behavioral measures, Brain activity measures and 1 more. Started Oct 2021; status: active, not recruiting.
02
Drugs
atomoxetine
Beyond the preview
Go deeper on NL-OMON49449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49449.